---
title: >-
  Racial and Ethnic Disparities in Access to Advanced Therapies for Atopic
  Dermatitis in the United States
description: >-
  Explore this publication on real-world evidence: Racial and Ethnic Disparities
  in Access to Advanced Therapies for Atopic Dermatitis in the United States.
date: '2026-01-01'
category: Publications
tags:
  - AbbVie
  - Abstract/Manuscript
  - Atopic Dermatitis (AD)
  - Care
  - 'No'
  - R&D
canonical_url: >-
  https://www.headwaterscience.com/resources/publications/ind-abbvie/racial-and-ethnic-disparities-in-access-to-advanced/
source: Headwater
license: © 2026 Headwater. All rights reserved.
slug: racial-and-ethnic-disparities-in-access-to-advanced
id: 6SYQthLaVtfHwVBT6UcPK1
contentType: article
---

## Challenge

Despite racial and ethnic minorities bearing a disproportionate burden of moderate-to-severe AD, they are underrepresented in clinical trials and face documented barriers to accessing advanced systemic therapies. The real-world magnitude of these disparities—and whether they persist after controlling for disease severity and clinical factors—had not been quantified in a large US prospective registry.

## Solution

The TARGET-DERM AD registry was used to compare disease severity, comorbidities, and advanced systemic therapy utilization rates across Non-Hispanic White, Non-Hispanic Black, Hispanic, and Non-Hispanic Asian patient groups, with multivariable analyses adjusting for relevant clinical and demographic confounders.